Tisagenlecleucel CAR-T for relapsed/refractory diffuse large B-cell lymphoma, one therapy; two different clinical presentations. An urgent need to design adverse event predictors

Saved in:
Bibliographic Details
Published inActa haematologica polonica
Main Authors Tomasik, Jaromir, Drozd-Sokołowska, Joanna, Kacprzyk, Piotr, Tomaszewska, Agnieszka, Machowicz, Rafał, Urbanowska, Elżbieta, Witkowska, Samanta, Basak, Grzegorz Władysław
Format Journal Article
LanguageEnglish
Published 07.04.2023
Online AccessGet full text

Cover

More Information
ISSN:0001-5814
2300-7117
DOI:10.5603/AHP.a2023.2018